Hutchinson Center as Lead Academic Participating Site (U10)

哈钦森中心作为主要学术参与地点 (U10)

• 批准号: 8850832
• 负责人: FREDERICK APPELBAUM
• 金额: $ 55.77万
• 依托单位: FRED HUTCHINSON CANCER RESEARCH CENTER
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-05-20 至 2019-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8850832
• 关键词: Adult; Alaska; American College of Radiology Imaging Network; Appointment; Area; Cancer Center; Cancer Hospital; Child; Clinical; Clinical Research; Clinical Trials; Clinical Trials Network; Conduct Clinical Trials; Country; Development; Diagnosis; Disease; Educational process of instructing; Enrollment; Faculty; Fred Hutchinson Cancer Research Center; Goals; Health; Idaho; Image; Individual; Institution; Joints; Lead; Leadership; Malignant Neoplasms; Mission; Montana; NCI Center for Cancer Research; National Clinical Trials Network; Occupational activity of managing finances; Pacific Northwest; Patients; Research; Research Infrastructure; Services; Shapes; Site; Southwest Oncology Group; Structure; System; Time; United States; Universities; Washington; Work; Wyoming; anticancer research; base; cancer care; cancer prevention; cancer therapy; clinical care; health care service organization; innovation; insight; member; next generation; novel strategies; organizational structure; pre-clinical; programs; research study

DESCRIPTION (provided by applicant): The goal of the NCI National Clinical Trials Network (NCTN) is to develop and conduct state-of-the-art cancer treatment and advanced imaging clinical trials, especially large, definitive multi-institutional trials evaluating new cancer therpies and related clinical approaches. NCTN Lead Academic Participating Sites (LAPS) are one component of this network and will provide scientific leadership in the development and conduct of NCTN clinical trials in association with one or more adult Network Groups as well as substantial accrual to clinical trials conducted across the entire NTCN. The Fred Hutchinson Cancer Research Center (FHCRC) is among the nation's leading cancer centers and is the only NCI-designated comprehensive cancer research center serving the WWAMI (Washington, Wyoming, Alaska, Montana and Idaho) region. The broad and deep pre-clinical and clinical research programs at the FHCRC will support the NCTN Program in three major ways: (1) The scientific expertise of the members of the FHCRC will continue to contribute to the leadership of the NCTN program through their activities directly at the NCI and in SWOG, NRG and ACRIN. (2) The innovative pre-clinical and clinical research studies at the FHCRC will provide the preliminary information necessary to shape the next generation of cooperative group trials. (3) The large patient base at the FHCRC combined with expert clinicians and clinical trials infrastructure will assure substantial accrual to NCTN trials. Fred Hutchinson Cancer Research Center and its partners are committed to the goals of the National Clinical Trials Network (NCTN) and will work to provide leadership for our nation's clinical trials network.

描述（由申请人提供）：NCI 国家临床试验网络 (NCTN) 的目标是开发和开展最先进的癌症治疗和先进影像临床试验，特别是评估新癌症疗法和相关临床方法的大型、明确的多机构试验。 NCTN 牵头学术参与中心 (LAPS) 是该网络的组成部分，将在与一个或多个成人网络团体联合开展 NCTN 临床试验的开发和实施方面提供科学领导，并为整个 NTCN 内开展的临床试验提供大量收益。 Fred Hutchinson 癌症研究中心 (FHCRC) 是美国领先的癌症中心之一，也是唯一一家 NCI 指定为 WWAMI（华盛顿、怀俄明、阿拉斯加、蒙大拿和爱达荷）地区提供服务的综合癌症研究中心。 FHCRC 广泛而深入的临床前和临床研究计划将以三种主要方式支持 NCTN 计划：(1) FHCRC 成员的科学专业知识将继续通过他们在 NCI 以及 SWOG、NRG 和 ACRIN 中的活动，继续为 NCTN 计划的领导做出贡献。 (2) FHCRC 的创新临床前和临床研究将为塑造下一代合作团体试验提供必要的初步信息。 (3) FHCRC 庞大的患者基础加上专家临床医生和临床试验基础设施将确保 NCTN 试验获得大量收益。 Fred Hutchinson 癌症研究中心及其合作伙伴致力于实现国家临床试验网络 (NCTN) 的目标，并将努力为我们国家的临床试验网络提供领导力。